Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 6 records, 1 pages
Search For: Remimazolam
Global Remimazolam Supply, Demand and Key Producers, 2024-2030
29 Feb 2024
Pharma & Healthcare
The global Remimazolam market size is expected to reach $ 619.7 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Remimazolam Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
04 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Remimazolam market size was valued at USD 438.3 million in 2023 and is forecast to a readjusted size of USD 619.7 million by 2030 with a CAGR of 5.1% during review period.
USD3480.00
Add To Cart
Global Remimazolam Besylate for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
15 Aug 2024
Pharma & Healthcare
Remimazolam Besylate for Injection
Remimazolam besylate for injection is a sedative and anesthetic agent used for inducing and maintaining sedation, particularly in procedural sedation and during surgeries. It's a rapid-onset and short-acting benzodiazepine derivative, offering controlled and reversible sedation with minimal cardiovascular and respiratory effects. Its fast metabolism allows for quick recovery after sedation.
USD3480.00
Add To Cart
Global Remimazolam Besylate for Injection Supply, Demand and Key Producers, 2024-2030
15 Aug 2024
Pharma & Healthcare
Remimazolam Besylate for Injection
Remimazolam besylate for injection is a sedative and anesthetic agent used for inducing and maintaining sedation, particularly in procedural sedation and during surgeries. It's a rapid-onset and short-acting benzodiazepine derivative, offering controlled and reversible sedation with minimal cardiovascular and respiratory effects. Its fast metabolism allows for quick recovery after sedation.
USD4480.00
Add To Cart
Global Remimazolam Supply, Demand and Key Producers, 2023-2029
23 Jan 2023
Pharma & Healthcare
The global Remimazolam market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Remimazolam Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
10 Jan 2023
Pharma & Healthcare
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Remimazolam
Total: 6 records, 1 pages
The global Remimazolam market size is expected to reach $ 619.7 million by 2030, rising at a market growth of 5.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Remimazolam market size was valued at USD 438.3 million in 2023 and is forecast to a readjusted size of USD 619.7 million by 2030 with a CAGR of 5.1% during review period.
USD3480.00
Add To Cart
Remimazolam besylate for injection is a sedative and anesthetic agent used for inducing and maintaining sedation, particularly in procedural sedation and during surgeries. It's a rapid-onset and short-acting benzodiazepine derivative, offering controlled and reversible sedation with minimal cardiovascular and respiratory effects. Its fast metabolism allows for quick recovery after sedation.
USD3480.00
Add To Cart
Remimazolam besylate for injection is a sedative and anesthetic agent used for inducing and maintaining sedation, particularly in procedural sedation and during surgeries. It's a rapid-onset and short-acting benzodiazepine derivative, offering controlled and reversible sedation with minimal cardiovascular and respiratory effects. Its fast metabolism allows for quick recovery after sedation.
USD4480.00
Add To Cart
The global Remimazolam market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>